SDI
Kyle Heaton has a long career in business development and account management in the telecommunications industry. Kyle started their career at Sprint in 1985 as a National Account Manager and worked there until 1993. Kyle then joined MCI Telecommunications as a National Account Manager and stayed with the company until 2000. From 2000 to 2004, they worked at AT&T as a NAM. In 2003, they moved to Verizon Business (former MCI) and worked as a NAM. Kyle then joined SDI Enterprises in 2007 as Director of Business Development and remained there until 2010. Kyle also worked at SDI as Director of Business Development without a specified end date. Currently, there is no available information on their recent work experience.
Kyle Heaton attended Lake Superior State University from 1979 to 1983. No degree or field of study information is available for this period.
This person is not in any offices
SDI
On October 31, 2011, IMS Health completed the purchase of SDI Health, a Pennsylvania-based healthcare market insights and analytics firm. The acquisition brings together both companies’ considerable patient, specialty and managed markets information assets and services capabilities to provide a full, 360-degree view of the entire patient experience. IMS is now positioned to deliver more innovative and comprehensive information services to a broader set of stakeholders, including pharma manufacturers, public and private payers, healthcare providers, pharmacies and healthcare institutions, and other key constituents. ABOUT IMS IMS Health is the leading provider of information, services and technology for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, sophisticated analytics, on-shore and off-shore commercial services, and software platforms to help clients better understand the performance and value of medicines. With a presence in 100+ countries and more than 55 years of industry experience, IMS serves leading decision makers in healthcare, including pharmaceutical manufacturers and distributors, providers, payers, government agencies, policymakers, researchers and the financial community. Additional information is available at http://www.imshealth.com.